| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |